BioNTech SE

NASDAQ: BNTX · Real-Time Price · USD
113.54
0.84 (0.75%)
At close: Aug 15, 2025, 3:59 PM
113.81
0.24%
After-hours: Aug 15, 2025, 07:27 PM EDT

BioNTech SE Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.76B 11.66B 13.88B 1.69B
Short-Term Investments
7.02B 4.89B 189.4M 381.6M
Long-Term Investments
1.25B 1.18B 80.2M 21.3M
Other Long-Term Assets
36.1M 83.47M 6.48M 800K
Receivables
1.52B 2.16B 7.15B 12.38B
Inventory
283.38M 357.7M 439.6M 502.5M
Other Current Assets
212.7M 460M 272.3M 113.8M
Total Current Assets
18.8B 19.53B 21.92B 15.07B
Property-Plant & Equipment
1.18B 971.6M 821.1M 520.4M
Goodwill & Intangibles
1.17B 1.17B 219.7M 202.4M
Total Long-Term Assets
3.73B 3.48B 1.36B 758.5M
Total Assets
22.53B 23.01B 23.28B 15.83B
Account Payables
426.7M 354M 204.1M 160M
Deferred Revenue
294.9M 353.59M 76.88M 189.1M
Short-Term Debt
39.5M 28.1M 36M 129.9M
Other Current Liabilities
1.76B 810.27M 2.03B 3.16B
Total Current Liabilities
2.52B 2.07B 2.95B 3.48B
Long-Term Debt
214.7M 191M 176.2M 171.6M
Other Long-Term Liabilities
155.3M 60.75M 41.98M 130.2M
Total Long-Term Liabilities
595.4M 689.9M 272.9M 455.5M
Total Liabilities
3.12B 2.76B 3.22B 3.94B
Total Debt
254.2M 219.1M 212.2M 301.5M
Common Stock
248.6M 248.6M 248.6M 246.3M
Retained Earnings
19.1B 19.76B 18.83B 9.88B
Comprehensive Income
-1.33B -985.41M -846.52M 1.77B
Shareholders Equity
19.41B 20.25B 20.06B 11.89B
Total Investments
8.28B 6.06B 269.6M 402.9M